Related references
Note: Only part of the references are listed.Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
G. M. Bell et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
An antigen-encapsulating nanoparticle platform for TH1/17 immune tolerance therapy
Derrick P. McCarthy et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Identification and characterisation of citrullinated antigen-specific B cells in peripheral blood of patients with rheumatoid arthritis
Priscilla F. Kerkman et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis
Anja Schwenzer et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
B Cells, Antibodies, and More
William Hoffman et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Expanding antigen-specific regulatory networks to treat autoimmunity
Xavier Clemente-Casares et al.
NATURE (2016)
Plasma cells as an innovative target in autoimmune disease with renal manifestations
Falk Hiepe et al.
NATURE REVIEWS NEPHROLOGY (2016)
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
Christoph T. Ellebrecht et al.
SCIENCE (2016)
Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
Md. Selim Ahmed et al.
IMMUNE NETWORK (2016)
In vitro eradication of citrullinated protein specific B-lymphocytes of rheumatoid arthritis patients by targeted bifunctional nanoparticles
Judit Pozsgay et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Biomarkers for antigen immunotherapy in allergy and type 1 diabetes
Jared M. Odegard et al.
CLINICAL IMMUNOLOGY (2015)
Autoantibodies in systemic autoimmune diseases: specificity and pathogenicity
Jolien Suurmond et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Nanoparticle-based autoantigen delivery to Treg-inducing liver sinusoidal endothelial cells enables control of autoimmunity in mice
Antonella Carambia et al.
JOURNAL OF HEPATOLOGY (2015)
Immune Tolerance Induction with Multiepitope Peptide Derived from Citrullinated Autoantigens Attenuates Arthritis Manifestations in Adjuvant Arthritis Rats
Smadar Gertel et al.
JOURNAL OF IMMUNOLOGY (2015)
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
Helen Benham et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Type 1 diabetes immunotherapy using polyclonal regulatory T cells
Jeffrey A. Bluestone et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Tolerogenic citrullinated peptide for arthritis
Smadar Gertel et al.
ONCOTARGET (2015)
Citrullination and carbamylation in the pathophysiology of rheumatoid arthritis
Ger J. M. Pruijn
FRONTIERS IN IMMUNOLOGY (2015)
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man
Verena K. Raker et al.
FRONTIERS IN IMMUNOLOGY (2015)
Selection and depletion of plasma cells based on the specificity of the secreted antibody
Adriano Taddeo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Roberto A. Maldonado et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Rituximab for Rheumatoid Arthritis
Marc D. Cohen et al.
RHEUMATOLOGY AND THERAPY (2015)
A Biodegradable Nanoparticle Platform for the Induction of Antigen-Specific Immune Tolerance for Treatment of Autoimmune Disease
Zoe Hunter et al.
ACS NANO (2014)
The fibrin-derived citrullinated peptide β60-74Cit60,72,74 bears the major ACPA epitope recognised by the rheumatoid arthritis-specific anticitrullinated fibrinogen autoantibodies and anti-CCP2 antibodies
M. Cornillet et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: The MRL-lpr mouse strain as a model
Helene Jeltsch-David et al.
AUTOIMMUNITY REVIEWS (2014)
Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
Melissa Noack et al.
AUTOIMMUNITY REVIEWS (2014)
The role of T cells in systemic lupus erythematosus: an update
Christine Konya et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
Recognition of new citrulline-containing peptide epitopes by autoantibodies produced in vivo and in vitro by B cells of rheumatoid arthritis patients
Eszter Szarka et al.
IMMUNOLOGY (2014)
Suppression of innate and adaptive B cell activation pathways by antibody coengagement of FcγRIIb and CD19
Daniel Szili et al.
MABS (2014)
Of mice and men: how animal models advance our understanding of T-cell function in RA
Tamas Kobezda et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
TREG-cell therapies for autoimmune rheumatic diseases
Makoto Miyara et al.
NATURE REVIEWS RHEUMATOLOGY (2014)
Chance, genetics, and the heterogeneity of disease and pathogenesis in systemic lupus erythematosus
Tony N. Marion et al.
SEMINARS IN IMMUNOPATHOLOGY (2014)
Citrulline-Specific Th1 Cells Are Increased in Rheumatoid Arthritis and Their Frequency Is Influenced by Disease Duration and Therapy
Eddie A. James et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
C. M. U. Hilkens et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2013)
Major pathogenic steps in human lupus can be effectively suppressed by nucleosomal histone peptide epitope-induced regulatory immunity
Li Zhang et al.
CLINICAL IMMUNOLOGY (2013)
Clinical optimization of antigen specific modulation of type 1 diabetes with the plasmid DNA platform
Peter Gottlieb et al.
CLINICAL IMMUNOLOGY (2013)
Vaccine against autoimmune disease: antigen-specific immunotherapy
Robert P. Anderson et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells
Jianmei W. Leavenworth et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
T cells out of control-impaired immune regulation in the inflamed joint
Ellen J. Wehrens et al.
NATURE REVIEWS RHEUMATOLOGY (2013)
A diverse array of genetic factors contribute to the pathogenesis of Systemic Lupus Erythematosus
Nicki Tiffin et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Transient B-Cell Depletion with Anti-CD20 in Combination with Proinsulin DNA Vaccine or Oral Insulin: Immunologic Effects and Efficacy in NOD Mice
Ghanashyam Sarikonda et al.
PLOS ONE (2013)
The Tolerogenic Peptide, hCDR1, Down-Regulates the Expression of Interferon-α in Murine and Human Systemic Lupus Erythematosus
Zev Sthoeger et al.
PLOS ONE (2013)
Plasmid-Encoded Proinsulin Preserves C-Peptide While Specifically Reducing Proinsulin-Specific CD8+ T Cells in Type 1 Diabetes
Bart O. Roep et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Safety and Efficacy of Antigen-Specific Regulatory T-Cell Therapy for Patients With Refractory Crohn's Disease
Pierre Desreumaux et al.
GASTROENTEROLOGY (2012)
Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection
Sarah Enouz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Moa Fransson et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Microparticles bearing encephalitogenic peptides induce T-cell tolerance and ameliorate experimental autoimmune encephalomyelitis
Daniel R. Getts et al.
NATURE BIOTECHNOLOGY (2012)
Why must T cells be cross-reactive?
Andrew K. Sewell
NATURE REVIEWS IMMUNOLOGY (2012)
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Makoto Miyara et al.
AUTOIMMUNITY REVIEWS (2011)
Antibody-Mediated Coengagement of FcγRIIb and B Cell Receptor Complex Suppresses Humoral Immunity in Systemic Lupus Erythematosus
Holly M. Horton et al.
JOURNAL OF IMMUNOLOGY (2011)
Tolerance Induced by Apoptotic Antigen-Coupled Leukocytes Is Induced by PD-L1+ and IL-10-Producing Splenic Macrophages and Maintained by T Regulatory Cells
Daniel R. Getts et al.
JOURNAL OF IMMUNOLOGY (2011)
RTL therapy for multiple sclerosis: A Phase I clinical study
Halina Offner et al.
JOURNAL OF NEUROIMMUNOLOGY (2011)
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
David Saadoun et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Circulating human B and plasma cells. Age-associated changes in counts and detailed characterization of circulating normal CD138- and CD138+ plasma cells
Anouk Caraux et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Toxin-Coupled MHC Class I Tetramers Can Specifically Ablate Autoreactive CD8+ T Cells and Delay Diabetes in Nonobese Diabetic Mice
Benjamin G. Vincent et al.
JOURNAL OF IMMUNOLOGY (2010)
FOXP3+ regulatory T cells in the human immune system
Shimon Sakaguchi et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Abetimus sodium: a medication for the prevention of lupus nephritis flares
Diane M. Horowitz et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Antigen-Specific Suppression of Inflammatory Arthritis Using Liposomes
Christelle Capini et al.
JOURNAL OF IMMUNOLOGY (2009)
Phenotypic Characterization of Autoreactive B Cells - Checkpoints of B Cell Tolerance in Patients with Systemic Lupus Erythematosus
Annett M. Jacobi et al.
PLOS ONE (2009)
Phase 2 trial of a DNA vaccine encoding myelin basic protein for multiple sclerosis
Hideki Garren et al.
ANNALS OF NEUROLOGY (2008)
Abetimus sodium for renal flare in systemic lupus erythematosus
Mario H. Cardiel et al.
ARTHRITIS AND RHEUMATISM (2008)
Reduced CD4+,CD25- T cell sensitivity to the suppressive function of CD4+,CD25high, CD127-/low regulatory T cells in patients with active systemic lupus erythematosus
Ram Kumar Chowdary Venigalla et al.
ARTHRITIS AND RHEUMATISM (2008)
Anti-histones antibodies in systemic lupus erythematosus: Prevalence and frequency in neuropsychiatric lupus
Xiao-Yun Sun et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2008)
Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their FcγIIb receptor
Nikolina Mihaylova et al.
INTERNATIONAL IMMUNOLOGY (2008)
A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS
Sushmita Sinha et al.
JOURNAL OF NEUROSCIENCE (2007)
Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis
Danielle M. Turley et al.
JOURNAL OF IMMUNOLOGY (2007)
Tolerizing DNA vaccines for autoimmune arthritis
Peggy P. Ho et al.
AUTOIMMUNITY (2006)
A peptide based on the complementarity-determining region 1 of an autoantibody ameliorates lupus by up-regulating CD4+CD25+ cells and TGF-β
Amir Sharabi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs
D Bresson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
A suppressive oligodeoxynucleotide enhances the efficacy of myelin cocktail/IL-4-tolerizing DNA vaccination and treats autoimmune disease
PP Ho et al.
JOURNAL OF IMMUNOLOGY (2005)
Cellular and genetic mechanisms of self tolerance and autoimmunity
CC Goodnow et al.
NATURE (2005)
Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis
H Burkhardt et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Very low-dose tolerance with nucleosomal peptides controls lupus and induces potent regulatory T cell subsets
HK Kang et al.
JOURNAL OF IMMUNOLOGY (2005)
Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers
F Bischof et al.
JOURNAL OF IMMUNOLOGY (2004)
The usefulness and the limitations of animal models in identifying targets for therapy in arthritis
PH Wooley
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2004)
Self-representation in the thymus: An extended view
B Kyewski et al.
NATURE REVIEWS IMMUNOLOGY (2004)
First clinical trials of a new heteropolymer technology agent in normal healthy volunteers and patients with systemic lupus erythematosus: safety and proof of principle of the antigen-heteropolymer ETI-104
C Iking-Konert et al.
ANNALS OF THE RHEUMATIC DISEASES (2004)
DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy
JL Schultze et al.
TRENDS IN IMMUNOLOGY (2004)
Predominant autoantibody production by early human B cell precursors
H Wardemann et al.
SCIENCE (2003)
Identification of an antigen-specific B cell population
J Newman et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2003)
Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood
JD Trudeau et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
An immunomodulatory GpG oligonucleotide for the treatment of autoimmunity via the innate and adaptive immune systems
PP Ho et al.
JOURNAL OF IMMUNOLOGY (2003)
Epitope spreading in immunemediated diseases: Implications for immunotherapy
CL Vanderlugt et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
B Sauter et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Share Paper
